What is the current valuation of the South America HERG screening market?

As of 2024, the South America HERG screening market was valued at 56.0 USD Million. Read More

What is the projected market valuation for the South America HERG screening market by 2035?

The market is projected to reach a valuation of 177.24 USD Million by 2035. Read More

What is the expected CAGR for the South America HERG screening market during the forecast period?

The expected CAGR for the South America HERG screening market from 2025 to 2035 is 11.04%. Read More

Which companies are considered key players in the South America HERG screening market?

Key players include Thermo Fisher Scientific, Agilent Technologies, PerkinElmer, and Bio-Rad Laboratories. Read More

What are the primary applications of HERG screening in South America?

The primary applications include Drug Development, Toxicology Studies, Cardiovascular Research, and Safety Pharmacology. Read More

How do pharmaceutical companies contribute to the HERG screening market?

Pharmaceutical companies are projected to account for 20.0 to 60.0 USD Million in market valuation. Read More

What technologies are utilized in HERG screening?

Technologies include Automated Screening Systems, Manual Screening Methods, and High-Throughput Screening. Read More

What test types are commonly used in HERG screening?

Common test types include Voltage Clamp Assays, Current Clamp Assays, and Patch Clamp Techniques. Read More

What role do Contract Research Organizations play in the HERG screening market?

Contract Research Organizations are expected to contribute between 15.0 and 45.0 USD Million to the market. Read More

What is the significance of the projected growth in the HERG screening market?

The projected growth indicates a rising demand for HERG screening, reflecting advancements in drug safety and efficacy testing. Read More

South America hERG Screening Market

ID: MRFR/HC/51280-HCR

200 Pages

Vikita Thakur

Last Updated: February 06, 2026

South America hERG screening Market Research Report By Type (Gene KCNH2, Mutant KCNH2), By Ion Channel (Voltage Gated, Ligand Gated), By Application (Antiarrhythmic, Antipsychotic, Antibiotics, Others) and By Regional (Brazil, Mexico, Argentina, Rest of South America) - Growth & Industry Forecast 2025 To 2035

South America hERG Screening Market

Market Size

Forecast Period2025 - 2035

CAGR (2025 - 2035)10.63%

2024 Market Size$ 56 Million

2025 Market Size$ 61.95 Million

2035 Market Size$ 170.2 Million

Key Players

Thermo Fisher Scientific

Charles River Laboratories

Eurofins Scientific

Celerion

CROMSOURCE

Inotiv

Trends

Regulatory Focus on Cardiac Safety
Technological Advancements in Screening Methods
Collaborative Research Initiatives

Opportunities

Rising Cardiovascular Disease Incidence
Investment in Biopharmaceutical Research
Growing Awareness of Drug-Induced Arrhythmias

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Healthcare, BY Application (USD Million)
  1. 4.1.1 Cardiovascular Research
  2. 4.1.2 Drug Development
  3. 4.1.3 Toxicology Studies
  4. 4.1.4 Safety Pharmacology
2. 4.2 Healthcare, BY End Use (USD Million)
  1. 4.2.1 Pharmaceutical Companies
  2. 4.2.2 Contract Research Organizations
  3. 4.2.3 Academic Institutions
  4. 4.2.4 Biotechnology Firms
3. 4.3 Healthcare, BY Technology (USD Million)
  1. 4.3.1 Automated Screening Systems
  2. 4.3.2 Manual Screening Methods
  3. 4.3.3 High-Throughput Screening
  4. 4.3.4 Electrophysiology Techniques
4. 4.4 Healthcare, BY Test Type (USD Million)
  1. 4.4.1 Voltage Clamp Assays
  2. 4.4.2 Current Clamp Assays
  3. 4.4.3 Patch Clamp Techniques
  4. 4.4.4 Cell-Based Assays
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Healthcare
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Thermo Fisher Scientific (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Agilent Technologies (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 PerkinElmer (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Bio-Rad Laboratories (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Charles River Laboratories (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Celerion (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Celerion (BR)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Eisai Co., Ltd. (JP)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 Hikma Pharmaceuticals (GB)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 SOUTH AMERICA MARKET ANALYSIS BY APPLICATION
3. 6.3 SOUTH AMERICA MARKET ANALYSIS BY END USE
4. 6.4 SOUTH AMERICA MARKET ANALYSIS BY TECHNOLOGY
5. 6.5 SOUTH AMERICA MARKET ANALYSIS BY TEST TYPE
6. 6.6 KEY BUYING CRITERIA OF HEALTHCARE
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF HEALTHCARE
9. 6.9 DRIVERS IMPACT ANALYSIS: HEALTHCARE
10. 6.10 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
11. 6.11 SUPPLY / VALUE CHAIN: HEALTHCARE
12. 6.12 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
13. 6.13 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Million)
14. 6.14 HEALTHCARE, BY END USE, 2024 (% SHARE)
15. 6.15 HEALTHCARE, BY END USE, 2024 TO 2035 (USD Million)
16. 6.16 HEALTHCARE, BY TECHNOLOGY, 2024 (% SHARE)
17. 6.17 HEALTHCARE, BY TECHNOLOGY, 2024 TO 2035 (USD Million)
18. 6.18 HEALTHCARE, BY TEST TYPE, 2024 (% SHARE)
19. 6.19 HEALTHCARE, BY TEST TYPE, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY APPLICATION, 2026-2035 (USD Million)
  2. 7.2.2 BY END USE, 2026-2035 (USD Million)
  3. 7.2.3 BY TECHNOLOGY, 2026-2035 (USD Million)
  4. 7.2.4 BY TEST TYPE, 2026-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

South America South America hERG Screening Market Segmentation

South America hERG Screening Market By Application (USD Million, 2022-2035)

Cardiovascular Research
Drug Development
Toxicology Studies
Safety Pharmacology

South America hERG Screening Market By End Use (USD Million, 2022-2035)

Pharmaceutical Companies
Contract Research Organizations
Academic Institutions
Biotechnology Firms

South America hERG Screening Market By Technology (USD Million, 2022-2035)

Automated Screening Systems
Manual Screening Methods
High-Throughput Screening
Electrophysiology Techniques

South America hERG Screening Market By Test Type (USD Million, 2022-2035)

Voltage Clamp Assays
Current Clamp Assays
Patch Clamp Techniques
Cell-Based Assays

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”